nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Cardiac arrest—Doxorubicin—ovarian cancer	0.000929	0.000929	CcSEcCtD
Meropenem—Diarrhoea—Vinorelbine—ovarian cancer	0.000923	0.000923	CcSEcCtD
Meropenem—Dysgeusia—Docetaxel—ovarian cancer	0.000923	0.000923	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—ovarian cancer	0.000918	0.000918	CcSEcCtD
Meropenem—Nausea—Melphalan—ovarian cancer	0.000917	0.000917	CcSEcCtD
Meropenem—Confusional state—Paclitaxel—ovarian cancer	0.000915	0.000915	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000915	0.000915	CcSEcCtD
Meropenem—Asthma—Epirubicin—ovarian cancer	0.000912	0.000912	CcSEcCtD
Meropenem—Back pain—Docetaxel—ovarian cancer	0.000912	0.000912	CcSEcCtD
Meropenem—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000907	0.000907	CcSEcCtD
Meropenem—Oedema—Paclitaxel—ovarian cancer	0.000907	0.000907	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—ovarian cancer	0.000903	0.000903	CcSEcCtD
Meropenem—Infection—Paclitaxel—ovarian cancer	0.000901	0.000901	CcSEcCtD
Meropenem—Shock—Paclitaxel—ovarian cancer	0.000893	0.000893	CcSEcCtD
Meropenem—Dizziness—Vinorelbine—ovarian cancer	0.000892	0.000892	CcSEcCtD
Meropenem—Nervous system disorder—Paclitaxel—ovarian cancer	0.00089	0.00089	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—ovarian cancer	0.000889	0.000889	CcSEcCtD
Meropenem—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000888	0.000888	CcSEcCtD
Meropenem—Tachycardia—Paclitaxel—ovarian cancer	0.000886	0.000886	CcSEcCtD
Meropenem—Skin disorder—Paclitaxel—ovarian cancer	0.000881	0.000881	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000879	0.000879	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000879	0.000879	CcSEcCtD
Meropenem—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000877	0.000877	CcSEcCtD
Meropenem—Anaemia—Docetaxel—ovarian cancer	0.000871	0.000871	CcSEcCtD
Meropenem—Anorexia—Paclitaxel—ovarian cancer	0.000865	0.000865	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000861	0.000861	CcSEcCtD
Meropenem—Vomiting—Vinorelbine—ovarian cancer	0.000858	0.000858	CcSEcCtD
Meropenem—Dysuria—Epirubicin—ovarian cancer	0.000853	0.000853	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—ovarian cancer	0.000853	0.000853	CcSEcCtD
Meropenem—Rash—Vinorelbine—ovarian cancer	0.000851	0.000851	CcSEcCtD
Meropenem—Dermatitis—Vinorelbine—ovarian cancer	0.00085	0.00085	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—ovarian cancer	0.00085	0.00085	CcSEcCtD
Meropenem—Hypotension—Paclitaxel—ovarian cancer	0.000848	0.000848	CcSEcCtD
Meropenem—Headache—Vinorelbine—ovarian cancer	0.000845	0.000845	CcSEcCtD
Meropenem—Syncope—Docetaxel—ovarian cancer	0.000845	0.000845	CcSEcCtD
Meropenem—Asthma—Doxorubicin—ovarian cancer	0.000844	0.000844	CcSEcCtD
Meropenem—Leukopenia—Docetaxel—ovarian cancer	0.000844	0.000844	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—ovarian cancer	0.000836	0.000836	CcSEcCtD
Meropenem—Loss of consciousness—Docetaxel—ovarian cancer	0.000828	0.000828	CcSEcCtD
Meropenem—Cough—Docetaxel—ovarian cancer	0.000822	0.000822	CcSEcCtD
Meropenem—Insomnia—Paclitaxel—ovarian cancer	0.000821	0.000821	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—ovarian cancer	0.000818	0.000818	CcSEcCtD
Meropenem—Paraesthesia—Paclitaxel—ovarian cancer	0.000815	0.000815	CcSEcCtD
Meropenem—Hypertension—Docetaxel—ovarian cancer	0.000814	0.000814	CcSEcCtD
Meropenem—Infestation—Epirubicin—ovarian cancer	0.000813	0.000813	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—ovarian cancer	0.000813	0.000813	CcSEcCtD
Meropenem—Dyspnoea—Paclitaxel—ovarian cancer	0.000809	0.000809	CcSEcCtD
Meropenem—Somnolence—Paclitaxel—ovarian cancer	0.000807	0.000807	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000806	0.000806	CcSEcCtD
Meropenem—Chest pain—Docetaxel—ovarian cancer	0.000802	0.000802	CcSEcCtD
Meropenem—Nausea—Vinorelbine—ovarian cancer	0.000801	0.000801	CcSEcCtD
Meropenem—Renal failure—Epirubicin—ovarian cancer	0.0008	0.0008	CcSEcCtD
Meropenem—Dyspepsia—Paclitaxel—ovarian cancer	0.000799	0.000799	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000797	0.000797	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000797	0.000797	CcSEcCtD
Meropenem—Jaundice—Epirubicin—ovarian cancer	0.000793	0.000793	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—ovarian cancer	0.000789	0.000789	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—ovarian cancer	0.000789	0.000789	CcSEcCtD
Meropenem—Decreased appetite—Paclitaxel—ovarian cancer	0.000789	0.000789	CcSEcCtD
Meropenem—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000783	0.000783	CcSEcCtD
Meropenem—Sweating—Epirubicin—ovarian cancer	0.00078	0.00078	CcSEcCtD
Meropenem—Constipation—Paclitaxel—ovarian cancer	0.000776	0.000776	CcSEcCtD
Meropenem—Pain—Paclitaxel—ovarian cancer	0.000776	0.000776	CcSEcCtD
Meropenem—Confusional state—Docetaxel—ovarian cancer	0.000776	0.000776	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000769	0.000769	CcSEcCtD
Meropenem—Anaphylactic shock—Docetaxel—ovarian cancer	0.000769	0.000769	CcSEcCtD
Meropenem—Oedema—Docetaxel—ovarian cancer	0.000769	0.000769	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—ovarian cancer	0.000767	0.000767	CcSEcCtD
Meropenem—Infection—Docetaxel—ovarian cancer	0.000764	0.000764	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—ovarian cancer	0.000759	0.000759	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—ovarian cancer	0.000757	0.000757	CcSEcCtD
Meropenem—Shock—Docetaxel—ovarian cancer	0.000757	0.000757	CcSEcCtD
Meropenem—Nervous system disorder—Docetaxel—ovarian cancer	0.000754	0.000754	CcSEcCtD
Meropenem—Thrombocytopenia—Docetaxel—ovarian cancer	0.000753	0.000753	CcSEcCtD
Meropenem—Infestation—Doxorubicin—ovarian cancer	0.000753	0.000753	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—ovarian cancer	0.000753	0.000753	CcSEcCtD
Meropenem—Tachycardia—Docetaxel—ovarian cancer	0.000751	0.000751	CcSEcCtD
Meropenem—Feeling abnormal—Paclitaxel—ovarian cancer	0.000748	0.000748	CcSEcCtD
Meropenem—Skin disorder—Docetaxel—ovarian cancer	0.000747	0.000747	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000746	0.000746	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—ovarian cancer	0.000743	0.000743	CcSEcCtD
Meropenem—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000742	0.000742	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—ovarian cancer	0.00074	0.00074	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000738	0.000738	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—ovarian cancer	0.000734	0.000734	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—ovarian cancer	0.000734	0.000734	CcSEcCtD
Meropenem—Anorexia—Docetaxel—ovarian cancer	0.000733	0.000733	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—ovarian cancer	0.00073	0.00073	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—ovarian cancer	0.00073	0.00073	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—ovarian cancer	0.000725	0.000725	CcSEcCtD
Meropenem—Sweating—Doxorubicin—ovarian cancer	0.000722	0.000722	CcSEcCtD
Meropenem—Urticaria—Paclitaxel—ovarian cancer	0.000721	0.000721	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—ovarian cancer	0.000719	0.000719	CcSEcCtD
Meropenem—Hypotension—Docetaxel—ovarian cancer	0.000719	0.000719	CcSEcCtD
Meropenem—Abdominal pain—Paclitaxel—ovarian cancer	0.000717	0.000717	CcSEcCtD
Meropenem—Body temperature increased—Paclitaxel—ovarian cancer	0.000717	0.000717	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000712	0.000712	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—ovarian cancer	0.00071	0.00071	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—ovarian cancer	0.000702	0.000702	CcSEcCtD
Meropenem—Insomnia—Docetaxel—ovarian cancer	0.000696	0.000696	CcSEcCtD
Meropenem—Paraesthesia—Docetaxel—ovarian cancer	0.000691	0.000691	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—ovarian cancer	0.00069	0.00069	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—ovarian cancer	0.000688	0.000688	CcSEcCtD
Meropenem—Dyspnoea—Docetaxel—ovarian cancer	0.000686	0.000686	CcSEcCtD
Meropenem—Somnolence—Docetaxel—ovarian cancer	0.000684	0.000684	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—ovarian cancer	0.000679	0.000679	CcSEcCtD
Meropenem—Dyspepsia—Docetaxel—ovarian cancer	0.000677	0.000677	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—ovarian cancer	0.000676	0.000676	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—ovarian cancer	0.000676	0.000676	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—ovarian cancer	0.000671	0.000671	CcSEcCtD
Meropenem—Decreased appetite—Docetaxel—ovarian cancer	0.000669	0.000669	CcSEcCtD
Meropenem—Hypersensitivity—Paclitaxel—ovarian cancer	0.000669	0.000669	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—ovarian cancer	0.000666	0.000666	CcSEcCtD
Meropenem—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000664	0.000664	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—ovarian cancer	0.00066	0.00066	CcSEcCtD
Meropenem—Pain—Docetaxel—ovarian cancer	0.000658	0.000658	CcSEcCtD
Meropenem—Constipation—Docetaxel—ovarian cancer	0.000658	0.000658	CcSEcCtD
Meropenem—Chills—Epirubicin—ovarian cancer	0.000655	0.000655	CcSEcCtD
Meropenem—Asthenia—Paclitaxel—ovarian cancer	0.000651	0.000651	CcSEcCtD
Meropenem—Pruritus—Paclitaxel—ovarian cancer	0.000642	0.000642	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—ovarian cancer	0.000639	0.000639	CcSEcCtD
Meropenem—Erythema—Epirubicin—ovarian cancer	0.000636	0.000636	CcSEcCtD
Meropenem—Feeling abnormal—Docetaxel—ovarian cancer	0.000634	0.000634	CcSEcCtD
Meropenem—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000629	0.000629	CcSEcCtD
Meropenem—Flatulence—Epirubicin—ovarian cancer	0.000626	0.000626	CcSEcCtD
Meropenem—Tension—Epirubicin—ovarian cancer	0.000624	0.000624	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—ovarian cancer	0.000622	0.000622	CcSEcCtD
Meropenem—Diarrhoea—Paclitaxel—ovarian cancer	0.000621	0.000621	CcSEcCtD
Meropenem—Nervousness—Epirubicin—ovarian cancer	0.000617	0.000617	CcSEcCtD
Meropenem—Back pain—Epirubicin—ovarian cancer	0.000615	0.000615	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—ovarian cancer	0.00061	0.00061	CcSEcCtD
Meropenem—Body temperature increased—Docetaxel—ovarian cancer	0.000608	0.000608	CcSEcCtD
Meropenem—Abdominal pain—Docetaxel—ovarian cancer	0.000608	0.000608	CcSEcCtD
Meropenem—Chills—Doxorubicin—ovarian cancer	0.000606	0.000606	CcSEcCtD
Meropenem—Dizziness—Paclitaxel—ovarian cancer	0.0006	0.0006	CcSEcCtD
Meropenem—Erythema—Doxorubicin—ovarian cancer	0.000588	0.000588	CcSEcCtD
Meropenem—Anaemia—Epirubicin—ovarian cancer	0.000588	0.000588	CcSEcCtD
Meropenem—Agitation—Epirubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—ovarian cancer	0.00058	0.00058	CcSEcCtD
Meropenem—Tension—Doxorubicin—ovarian cancer	0.000577	0.000577	CcSEcCtD
Meropenem—Vomiting—Paclitaxel—ovarian cancer	0.000577	0.000577	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—ovarian cancer	0.000576	0.000576	CcSEcCtD
Meropenem—Malaise—Epirubicin—ovarian cancer	0.000573	0.000573	CcSEcCtD
Meropenem—Rash—Paclitaxel—ovarian cancer	0.000572	0.000572	CcSEcCtD
Meropenem—Dermatitis—Paclitaxel—ovarian cancer	0.000572	0.000572	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—ovarian cancer	0.000571	0.000571	CcSEcCtD
Meropenem—Syncope—Epirubicin—ovarian cancer	0.00057	0.00057	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—ovarian cancer	0.000569	0.000569	CcSEcCtD
Meropenem—Back pain—Doxorubicin—ovarian cancer	0.000569	0.000569	CcSEcCtD
Meropenem—Headache—Paclitaxel—ovarian cancer	0.000568	0.000568	CcSEcCtD
Meropenem—Hypersensitivity—Docetaxel—ovarian cancer	0.000567	0.000567	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—ovarian cancer	0.000559	0.000559	CcSEcCtD
Meropenem—Cough—Epirubicin—ovarian cancer	0.000555	0.000555	CcSEcCtD
Meropenem—Asthenia—Docetaxel—ovarian cancer	0.000552	0.000552	CcSEcCtD
Meropenem—Hypertension—Epirubicin—ovarian cancer	0.000549	0.000549	CcSEcCtD
Meropenem—Pruritus—Docetaxel—ovarian cancer	0.000544	0.000544	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—ovarian cancer	0.000544	0.000544	CcSEcCtD
Meropenem—Chest pain—Epirubicin—ovarian cancer	0.000541	0.000541	CcSEcCtD
Meropenem—Agitation—Doxorubicin—ovarian cancer	0.00054	0.00054	CcSEcCtD
Meropenem—Anxiety—Epirubicin—ovarian cancer	0.000539	0.000539	CcSEcCtD
Meropenem—Nausea—Paclitaxel—ovarian cancer	0.000539	0.000539	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000537	0.000537	CcSEcCtD
Meropenem—Malaise—Doxorubicin—ovarian cancer	0.00053	0.00053	CcSEcCtD
Meropenem—Syncope—Doxorubicin—ovarian cancer	0.000527	0.000527	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—ovarian cancer	0.000526	0.000526	CcSEcCtD
Meropenem—Diarrhoea—Docetaxel—ovarian cancer	0.000526	0.000526	CcSEcCtD
Meropenem—Confusional state—Epirubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Meropenem—Oedema—Epirubicin—ovarian cancer	0.000519	0.000519	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—ovarian cancer	0.000519	0.000519	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—ovarian cancer	0.000517	0.000517	CcSEcCtD
Meropenem—Infection—Epirubicin—ovarian cancer	0.000515	0.000515	CcSEcCtD
Meropenem—Cough—Doxorubicin—ovarian cancer	0.000513	0.000513	CcSEcCtD
Meropenem—Shock—Epirubicin—ovarian cancer	0.00051	0.00051	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—ovarian cancer	0.000509	0.000509	CcSEcCtD
Meropenem—Dizziness—Docetaxel—ovarian cancer	0.000509	0.000509	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—ovarian cancer	0.000508	0.000508	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—ovarian cancer	0.000508	0.000508	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—ovarian cancer	0.000506	0.000506	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—ovarian cancer	0.000504	0.000504	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—ovarian cancer	0.000502	0.000502	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—ovarian cancer	0.000501	0.000501	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—ovarian cancer	0.000499	0.000499	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000497	0.000497	CcSEcCtD
Meropenem—Anorexia—Epirubicin—ovarian cancer	0.000494	0.000494	CcSEcCtD
Meropenem—Vomiting—Docetaxel—ovarian cancer	0.000489	0.000489	CcSEcCtD
Meropenem—Rash—Docetaxel—ovarian cancer	0.000485	0.000485	CcSEcCtD
Meropenem—Hypotension—Epirubicin—ovarian cancer	0.000485	0.000485	CcSEcCtD
Meropenem—Dermatitis—Docetaxel—ovarian cancer	0.000484	0.000484	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Meropenem—Headache—Docetaxel—ovarian cancer	0.000482	0.000482	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00048	0.00048	CcSEcCtD
Meropenem—Oedema—Doxorubicin—ovarian cancer	0.00048	0.00048	CcSEcCtD
Meropenem—Infection—Doxorubicin—ovarian cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Shock—Doxorubicin—ovarian cancer	0.000472	0.000472	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—ovarian cancer	0.000471	0.000471	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00047	0.00047	CcSEcCtD
Meropenem—Insomnia—Epirubicin—ovarian cancer	0.000469	0.000469	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—ovarian cancer	0.000468	0.000468	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—ovarian cancer	0.000466	0.000466	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—ovarian cancer	0.000466	0.000466	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000464	0.000464	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—ovarian cancer	0.000463	0.000463	CcSEcCtD
Meropenem—Somnolence—Epirubicin—ovarian cancer	0.000461	0.000461	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—ovarian cancer	0.000458	0.000458	CcSEcCtD
Meropenem—Nausea—Docetaxel—ovarian cancer	0.000457	0.000457	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—ovarian cancer	0.000457	0.000457	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—ovarian cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—ovarian cancer	0.000449	0.000449	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000448	0.000448	CcSEcCtD
Meropenem—Pain—Epirubicin—ovarian cancer	0.000444	0.000444	CcSEcCtD
Meropenem—Constipation—Epirubicin—ovarian cancer	0.000444	0.000444	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—ovarian cancer	0.000434	0.000434	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—ovarian cancer	0.000431	0.000431	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—ovarian cancer	0.000428	0.000428	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000424	0.000424	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—ovarian cancer	0.000423	0.000423	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—ovarian cancer	0.000417	0.000417	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000414	0.000414	CcSEcCtD
Meropenem—Urticaria—Epirubicin—ovarian cancer	0.000412	0.000412	CcSEcCtD
Meropenem—Pain—Doxorubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Constipation—Doxorubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—ovarian cancer	0.000396	0.000396	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—ovarian cancer	0.000382	0.000382	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—ovarian cancer	0.000381	0.000381	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Asthenia—Epirubicin—ovarian cancer	0.000372	0.000372	CcSEcCtD
Meropenem—Pruritus—Epirubicin—ovarian cancer	0.000367	0.000367	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—ovarian cancer	0.000355	0.000355	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—ovarian cancer	0.000354	0.000354	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—ovarian cancer	0.000344	0.000344	CcSEcCtD
Meropenem—Dizziness—Epirubicin—ovarian cancer	0.000343	0.000343	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—ovarian cancer	0.00034	0.00034	CcSEcCtD
Meropenem—Vomiting—Epirubicin—ovarian cancer	0.00033	0.00033	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—ovarian cancer	0.000328	0.000328	CcSEcCtD
Meropenem—Rash—Epirubicin—ovarian cancer	0.000327	0.000327	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—ovarian cancer	0.000327	0.000327	CcSEcCtD
Meropenem—Headache—Epirubicin—ovarian cancer	0.000325	0.000325	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—ovarian cancer	0.000317	0.000317	CcSEcCtD
Meropenem—Nausea—Epirubicin—ovarian cancer	0.000308	0.000308	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—ovarian cancer	0.000305	0.000305	CcSEcCtD
Meropenem—Rash—Doxorubicin—ovarian cancer	0.000303	0.000303	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—ovarian cancer	0.000302	0.000302	CcSEcCtD
Meropenem—Headache—Doxorubicin—ovarian cancer	0.000301	0.000301	CcSEcCtD
Meropenem—Nausea—Doxorubicin—ovarian cancer	0.000285	0.000285	CcSEcCtD
